AURINIA PHARMACEUTICALS ($AUPH) posted quarterly earnings results on Monday, May 12th. The company reported earnings of $0.16 per share, beating estimates of $0.10 by $0.06. The company also reported revenue of $62,470,000, missing estimates of $62,766,312 by $-296,312.
You can see Quiver Quantitative's $AUPH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AURINIA PHARMACEUTICALS Insider Trading Activity
AURINIA PHARMACEUTICALS insiders have traded $AUPH stock on the open market 15 times in the past 6 months. Of those trades, 3 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $AUPH stock by insiders over the last 6 months:
- KEVIN TANG has made 3 purchases buying 1,200,000 shares for an estimated $10,822,000 and 0 sales.
- PETER GREENLEAF (Chief Executive Officer) has made 0 purchases and 2 sales selling 360,540 shares for an estimated $2,871,124.
- MATTHEW MAXWELL DONLEY (Chief Operating Officer) has made 0 purchases and 2 sales selling 124,893 shares for an estimated $994,424.
- STEPHEN P. ROBERTSON (EVP, General Counsel) has made 0 purchases and 2 sales selling 122,479 shares for an estimated $975,223.
- JOSEPH M MILLER (Chief Financial Officer) has made 0 purchases and 2 sales selling 118,013 shares for an estimated $939,611.
- GREG KEENAN (Chief Medical Officer) has made 0 purchases and 2 sales selling 20,544 shares for an estimated $166,262.
- KAREN L. SMITH sold 5,241 shares for an estimated $44,181
- JEFFREY ALLEN BAILEY sold 4,557 shares for an estimated $38,415
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AURINIA PHARMACEUTICALS Hedge Fund Activity
We have seen 101 institutional investors add shares of AURINIA PHARMACEUTICALS stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 1,800,000 shares (-22.0%) from their portfolio in Q4 2024, for an estimated $16,164,000
- TANG CAPITAL MANAGEMENT LLC added 1,200,000 shares (+16.6%) to their portfolio in Q4 2024, for an estimated $10,776,000
- ROCK SPRINGS CAPITAL MANAGEMENT LP removed 1,179,740 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $10,594,065
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,075,911 shares (+inf%) to their portfolio in Q4 2024, for an estimated $9,661,680
- POINT72 ASSET MANAGEMENT, L.P. added 849,621 shares (+inf%) to their portfolio in Q4 2024, for an estimated $7,629,596
- JUPITER ASSET MANAGEMENT LTD added 752,769 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,052,262
- LAZARD ASSET MANAGEMENT LLC added 461,430 shares (+341.9%) to their portfolio in Q4 2024, for an estimated $4,143,641
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
